相位角对维持性血液透析患者肌肉减少症与全因死亡间的修饰效应:一项单中心回顾性队列研究OA
The association effect of phase angle between sarcopenia and all-cause mortali-ty in maintenance hemodialysis patients:a single-center retrospective cohort study
目的 探讨相位角(PhA)对维持性血液透析(MHD)患者肌肉减少症与全因死亡关系的修饰效应。方法 选取2020年5月至2022年5月于苏州科技城医院治疗的130例MHD患者为研究对象,其中,肌肉减少症组48例,非肌肉减少症组82例。随访3年后显示,死亡组31例,生存组99例。采用加权广义加性模型和平滑曲线拟合分析PhA与肌肉减少症5条目量表(SARC-F)评分的关联。采用多因素Cox回归分析肌肉减少症、PhA与MHD患者全因死亡的关联,使用似然比检验判断PhA与肌肉减少症对全因死亡是否存在交互作用,并分析不同PhA水平下肌肉减少症与全因死亡的关联。使用广义线性模型评估PhA对肌肉减少症与全因死亡之间回归关系的影响。通过受试者操作特征(ROC)曲线及曲线下面积(AUC)预测全因死亡风险。采用Kaplan Meier法、Log rank检验分析患者生存率差异。结果 肌肉减少症组的年龄、全段甲状旁腺激素(iPTH)、C反应蛋白(CRP)、SARC-F评分明显高于非肌肉减少症组,尿素清除指数(Kt/V)、PhA等人体成分特征指标水平均明显低于非肌肉减少症组(P<0.05)。PhA水平与SARC-F评分呈负相关(P<0.001)。死亡组的年龄、CRP、SARC-F评分明显高于生存组,合并肌肉减少症比例、Kt/V、PhA等人体成分特征指标水平明显低于生存组(P<0.05)。高水平PhA是可降低MHD患者的全因死亡风险(HR=0.479,95%CI:0.271~0.748,P<0.001),肌肉减少症可增加MHD患者的全因死亡风险(HR=2.346,95%CI:1.679~3.021,P<0.001)。在合并肌肉减少症的患者中,PhA每降低1。,全因死亡的风险将会增加15.70%。随着PhA水平的升高,肌肉减少症与全因死亡之间的正关联关系逐渐减弱(P<0.001)。PhA预测全因死亡的AUC为0.889,cut-off值取4.15。时预测效能最佳。在肌肉减少症中,随着PhA水平的升高,MHD患者的全因死亡风险降低,非肌肉减少症组中,这一趋势仍然存在。结论 PhA降低是MHD患者全因死亡的危险因素,PhA对肌肉减少症与全因死亡的关系具有显著的修饰效应,随着PhA水平升高,肌肉减少症对死亡风险的增加作用逐渐减弱。
Objective To explore the modifying effect of phase angle(PhA)on the relationship between muscle wasting and all-cause mortality in patients undergoing maintenance hemodialysis(MHD).Methods A total of 130 MHD patients who were treated in Suzhou Science City Hospital from May 2020 to May 2022 were selected:48 in the muscle atrophy group and 82 in the non-muscle atrophy group.After a 3-year follow-up,31 were in the death group and 99 in the survival group.The weighted generalized additive model and smooth curve fitting were used to analyze the association between PhA and the 5-item SARC-F scale for sarcopenia.A multivariate Cox re-gression analysis was conducted to investigate the association between sarcopenia,PhA and all-cause mortality in MHD patients.The generalized linear model was used to evaluate the influence of PhA on the regression relation-ship between sarcopenia and total mortality.The ROC and AUC curve were used to predict the risk of total mor-tality.The Kaplan-Meier method and Log rank test were used to analyze the differences in survival rates of the patients.The interaction between PhA and sarcopenia on all-cause mortality,the odds ratio(OR)and 95%con-fidence interval(CI)of the risk of death were analyzed.Results The age,intact parathyroid hormone(iPTH),C-reactive protein(CRP),and SARC-F score of the muscle atrophy group were significantly higher than those of the non-muscle atrophy group,while the levels of body composition characteristics such as urea clearance index(Kt/V)and PhA were significantly lower than those of the non-muscle atrophy group(P<0.05).PhA levels were negatively correlated with SARC-F scores(P<0.001).The age,CRP and SARC-F score of the death group were significantly higher than those of the survival group,while the proportion of patients with muscle atro-phy,Kt/V and PhA and other body composition characteristic indicators were significantly lower than those of the survival group(P<0.05).High-level PhA can reduce the all-cause mortality risk of MHD patients(HR=0.479,95%CI:0.271-0.748,P<0.001).Muscle atrophy increased the all-cause mortality risk of MHD pa-tients(HR=2.346,95%CI:1.679-3.021,P<0.001).In patients with muscle atrophy,for every 1° de-crease in PhA level,the all-cause mortality risk will increase by 15.70%.As the PhA level increases,the posi-tive correlation between muscle atrophy and all-cause mortality gradually weakens(P<0.001).The AUC of PhA for predicting all-cause mortality was 0.889,and the cut-off value of 4.15° yielded the best predictive per-formance.In sarcopenia,the all-cause mortality risk of MHD patients decreased with the increase of PhA level,and this trend still existed in the non-sarcopenia group.High PhA × muscle atrophy,low PhA × non-muscle atro-phy,and low PhA × muscle atrophy all had an interactive effect on all-cause mortality(P<0.001).Conclusion A decrease in PhA is a risk factor for all-cause mortality in MHD patients.PhA has a significant modifying effect on the relationship between sarcopenia and all-cause mortality.As the level of PhA increases,the increasing effect of sarcopenia on the risk of death gradually weakens.
智佳;王晓禾;程波
南京大学医学院附属苏州医院暨苏州科技城医院肾内科 江苏苏州 215163南京大学医学院附属苏州医院暨苏州科技城医院肾内科 江苏苏州 215163南京大学医学院附属苏州医院暨苏州科技城医院影像科 江苏苏州 215163
医药卫生
相位角维持性血液透析肌肉减少症全因死亡修饰效应
phase anglemaintenance hemodialysismuscle atrophyall-cause mortalitymodifying effect
《遵义医科大学学报》 2026 (3)
269-279,11
苏州市科技发展计划项目(NO:SKYD2023092).
评论